0,981  0,001  TRPA1 agonist
0,887  0,003  Psychostimulant
0,872  0,001  Vanilloid 1 agonist
0,868  0,003  Angiogenesis stimulant
0,862  0,002  Antihypotensive
0,865  0,008  Antiinflammatory
0,841  0,005  CYP2C9 substrate
0,811  0,001  Vanilloid agonist
0,792  0,004  Myocardial infarction treatment
0,771  0,011  Teratogen
0,763  0,003  Antialcoholic
0,748  0,005  Bone diseases treatment
0,746  0,011  Embryotoxic
0,736  0,005  Antiosteoporotic
0,728  0,002  CYP2B6 inhibitor
0,735  0,017  Transcription factor NF kappa B inhibitor
0,722  0,006  CYP2C19 substrate
0,739  0,024  Apoptosis agonist
0,718  0,010  Alzheimer's disease treatment
0,709  0,006  NOS2 expression inhibitor
0,701  0,004  UGT1A4 substrate
0,701  0,006  Antiepileptic
0,697  0,004  Antianorexic
0,691  0,002  Cannabinoid CB2 receptor antagonist
0,691  0,005  Antiglaucomic
0,705  0,023  Caspase 9 stimulant
0,676  0,011  Chemoprotective
0,669  0,004  Diabetic retinopathy treatment
0,656  0,005  Sedative
0,650  0,009  Spasmolytic
0,638  0,000  Vanilloid 2 agonist
0,637  0,005  Antineoplastic (endocrine cancer)
0,626  0,002  Posttraumatic stress disorder treatment
0,621  0,011  Stroke treatment
0,593  0,003  5 Hydroxytryptamine uptake stimulant
0,600  0,010  Antiparasitic
0,596  0,014  Immunosuppressant
0,596  0,015  Sensitization
0,588  0,008  Antineurogenic pain
0,581  0,007  Antihelmintic
0,581  0,013  Antioxidant
0,557  0,006  Monophenol monooxygenase inhibitor
0,580  0,030  Analgesic
0,559  0,015  Antineoplastic (pancreatic cancer)
0,549  0,015  AR expression inhibitor
0,557  0,026  Antiparkinsonian
0,536  0,008  UGT1A1 substrate
0,540  0,021  Carcinogenic
0,558  0,042  Antineoplastic (breast cancer)
0,532  0,017  Proliferative diseases treatment
0,547  0,037  Antineoplastic (lung cancer)
0,516  0,012  Skin irritative effect
0,540  0,037  TNF expression inhibitor
0,506  0,004  UGT2B7 substrate
0,533  0,032  Antibacterial
0,502  0,007  Melanin inhibitor
0,506  0,011  Vascular (periferal) disease treatment
0,508  0,023  Antineoplastic (melanoma)
0,490  0,013  Antidiabetic symptomatic
0,477  0,001  Adenosine uptake inhibitor
0,504  0,028  Respiratory analeptic
0,480  0,005  Insulin secretagoues
0,503  0,032  Antipruritic, allergic
0,467  0,007  Abortion inducer
0,472  0,015  Dependence treatment
0,470  0,027  Antifungal
0,453  0,015  Antineoplastic (liver cancer)
0,445  0,010  Skin whitener
0,451  0,020  Nitric oxide antagonist
0,448  0,029  Analeptic
0,417  0,005  Antifungal enhancer
0,412  0,008  Pneumotoxic
0,429  0,025  Chemopreventive
0,453  0,049  Antileukemic
0,426  0,027  Cardiovascular analeptic
0,409  0,009  Bone formation stimulant
0,403  0,007  Antiviral (Influenza A)
0,422  0,028  Mutagenic
0,397  0,004  Cannabinoid receptor antagonist
0,411  0,021  Vasodilator
0,412  0,034  CTGF expression inhibitor
0,426  0,048  Antineoplastic (colorectal cancer)
0,406  0,029  UGT2B4 substrate
0,388  0,012  Antiacne
0,414  0,040  Caspase 3 stimulant
0,431  0,061  15-Lipoxygenase inhibitor
0,389  0,020  Eye irritation, high
0,401  0,036  Antineoplastic (cervical cancer)
0,407  0,043  Antineoplastic (ovarian cancer)
0,368  0,007  Renal failure treatment
0,406  0,049  Antineoplastic (colon cancer)
0,374  0,018  Antiviral (HIV)
0,403  0,049  Immunostimulant
0,373  0,023  UDP-glucuronosyltransferase substrate
0,365  0,016  Antiviral (Influenza)
0,360  0,013  Interferon gamma antagonist
0,406  0,061  CYP3A4 substrate
0,349  0,004  Movement disorders treatment
0,351  0,014  Hair growth stimulant
0,380  0,044  NOS3 expression inhibitor
0,337  0,004  TRPA1 antagonist
0,337  0,007  Autism spectrum disorders treatment
0,332  0,005  Antifungal (Cryptococcus)
0,329  0,004  Cannabinoid CB1 receptor antagonist
0,356  0,033  Amyotrophic lateral sclerosis treatment
0,387  0,069  CYP2C19 inhibitor
0,408  0,089  Antiarthritic
0,337  0,025  Muscle relaxant
0,330  0,018  Antipruritic, non-allergic
0,322  0,013  Antihelmintic (Nematodes)
0,306  0,003  TRPM8 blocker
0,342  0,040  Tumour necrosis factor alpha release inhibitor
0,309  0,015  Protein kinase stimulant
0,354  0,061  FMO1 substrate
0,326  0,036  DNA synthesis inhibitor
0,333  0,043  Free radical scavenger
0,349  0,062  ICAM1 expression inhibitor
0,331  0,045  Antiprotozoal (Leishmania)
0,345  0,061  Hepatic disorders treatment
0,364  0,081  GST A substrate
0,343  0,062  Immunomodulator
0,292  0,011  UGT2B9 substrate
0,332  0,054  Interleukin 2 agonist
0,286  0,009  Neuropathy treatment
0,301  0,025  VCAM1 expression inhibitor
0,295  0,021  Acaricide
0,357  0,084  Antiobesity
0,360  0,087  Antiprotozoal
0,291  0,021  Neurotrophic factor enhancer
0,333  0,065  CYP2D6 substrate
0,290  0,031  Sleep disorders treatment
0,323  0,064  Antineoplastic (brain cancer)
0,330  0,073  Prostate cancer treatment
0,318  0,063  Sodium/bile acid cotransporter inhibitor
0,272  0,023  Antineoplastic (gastric cancer)
0,255  0,010  Alcohol dehydrogenase substrate
0,321  0,076  Antithrombotic
0,310  0,066  Cardioprotectant
0,246  0,005  Inducible nitric-oxide synthase inhibitor
0,249  0,013  UGT2B10 substrate
0,297  0,062  Antihypercholesterolemic
0,262  0,028  Protein-tyrosine phosphatase inhibitor
0,295  0,063  UGT1A9 substrate
0,300  0,070  5 Hydroxytryptamine release stimulant
0,264  0,034  Antimutagenic
0,246  0,017  Protein-tyrosine phosphatase 1B inhibitor
0,243  0,018  DNA polymerase I inhibitor
0,272  0,047  Antihypertriglyceridemic
0,256  0,031  Antiviral (Herpes)
0,226  0,005  CYP2A6 inhibitor
0,278  0,057  Cytostatic
0,307  0,087  Cholesterol antagonist
0,249  0,030  Antiseptic
0,258  0,039  P-glycoprotein inhibitor
0,275  0,056  Cytotoxic
0,228  0,009  Aldehyde dehydrogenase substrate
0,239  0,022  Antidiarrheal
0,315  0,099  Ulceration
0,222  0,007  Actinic keratosis treatment
0,308  0,094  Antiprotozoal (Plasmodium)
0,260  0,046  Platelet adhesion inhibitor
0,284  0,074  Radioprotector
0,252  0,043  Hepatoprotectant
0,283  0,077  CYP1A2 substrate
0,220  0,014  SULT1A1 substrate
0,307  0,102  Cognition disorders treatment
0,315  0,112  Atherosclerosis treatment
0,209  0,008  Transcription factor NF kappa B stimulant
0,238  0,041  Insulin sensitizer
0,228  0,032  Carcinogenic, group 3
0,203  0,008  Prolactin inhibitor
0,254  0,060  UGT1A6 substrate
0,201  0,008  Electron transport complex I inhibitor
0,214  0,022  Neurotrophic factor
0,210  0,026  SULT1A3 substrate
0,208  0,025  Cholesterol synthesis inhibitor
0,187  0,006  Anabolic
0,180  0,002  Vanilloid 4 agonist
0,238  0,065  Antiulcerative
0,263  0,089  Hypoxia-inducible factor 1 alpha inhibitor
0,231  0,059  Septic shock treatment
0,176  0,005  Ca(v)3.1 blocker
0,210  0,041  Antineoplastic (carcinoma)
0,252  0,086  CYP1A2 inhibitor
0,200  0,036  Pancreatic disorders treatment
0,209  0,046  UGT1A3 substrate
0,312  0,152  Antidiabetic
0,312  0,152  Cyclophilin D inhibitor
0,183  0,023  Adenylate cyclase stimulant
0,196  0,037  Arachidonic acid antagonist
0,257  0,099  Anxiolytic
0,238  0,080  Antineoplastic (glioma)
0,252  0,100  FMO3 substrate
0,265  0,113  Apoptosis antagonist
0,168  0,023  UGT2B1 substrate
0,160  0,015  Antiprotozoal (Toxoplasma)
0,221  0,075  Peptidyltransferase inhibitor
0,169  0,025  Antiemetic
0,152  0,010  Ornithine decarboxylase inhibitor
0,194  0,053  Succinate dehydrogenase inhibitor
0,229  0,090  Antineoplastic (renal cancer)
0,182  0,044  Genotoxic
0,149  0,013  Cannabinoid receptor agonist
0,162  0,028  Antineoplastic antibiotic
0,169  0,035  Farnesoid X receptor antagonist
0,264  0,131  Calcium channel activator
0,252  0,119  Antihypertensive
0,194  0,061  Growth hormone agonist
0,142  0,011  Cannabinoid CB1 receptor agonist
0,212  0,083  RNA-directed DNA polymerase inhibitor
0,231  0,102  Lipoprotein disorders treatment
0,146  0,017  UGT2B11 substrate
0,137  0,008  SULT1A2 substrate
0,180  0,052  UGT2B15 substrate
0,225  0,098  Interleukin agonist
0,155  0,028  Photosensitizer
0,135  0,011  Glycine receptor antagonist
0,157  0,034  Microtubule formation inhibitor
0,181  0,059  Phospholipase C inhibitor
0,141  0,021  Antiviral (Coronavirus)
0,141  0,021  Antiviral (SARS coronavirus)
0,160  0,042  Interleukin 4 antagonist
0,125  0,008  5-Alpha-reductase inhibitor
0,144  0,028  Beta glucuronidase inhibitor
0,140  0,025  Antispirochetal
0,147  0,032  GABA C receptor antagonist
0,181  0,068  Sigma receptor agonist
0,166  0,055  Contraceptive
0,233  0,125  GST M1-1 substrate
0,169  0,063  Uterine stimulant
0,194  0,089  Antineoplastic (glioblastoma multiforme)
0,135  0,030  Nitric-oxide synthase inhibitor
0,146  0,043  Coagulant
0,258  0,155  CYP2C9 inhibitor
0,146  0,044  Growth stimulant
0,169  0,067  Prostate disorders treatment
0,211  0,110  Antineoplastic (sarcoma)
0,207  0,106  Hypoglycemic
0,221  0,121  Lipoxygenase inhibitor
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,195  0,102  Antineoplastic (lymphocytic leukemia)
0,130  0,038  Estrogen antagonist
0,137  0,047  Sphingosine 1-phosphate receptor 4 antagonist
0,133  0,043  Choleretic
0,114  0,024  ATPase (Vacuolar H+) inhibitor
0,145  0,056  Ca2+-transporting ATPase inhibitor
0,211  0,121  Renal disease treatment
0,136  0,047  Contraceptive female
0,198  0,110  Antipyretic
0,091  0,005  Retinoid X receptor agonist
0,118  0,034  Estrogen receptor beta antagonist
0,135  0,051  Retinopathy treatment
0,137  0,054  Proteasome inhibitor
0,169  0,086  Antirickettsial
0,112  0,030  Antiviral (Trachoma)
0,147  0,067  Antineoplastic (squamous cell carcinoma)
0,104  0,025  Estrogen receptor alpha antagonist
0,104  0,025  Interferon agonist
0,144  0,065  Anesthetic
0,189  0,110  Platelet antagonist
0,099  0,021  Glycine receptor agonist
0,138  0,061  Toll-Like receptor 2 antagonist
0,091  0,016  Interferon inducer
0,123  0,049  Expectorant
0,223  0,149  Antineoplastic (osteosarcoma)
0,150  0,076  Acute respiratory distress syndrome (ARDS) treatment
0,115  0,042  Antihypermotility
0,167  0,097  Anesthetic general
0,099  0,028  CDC25A inhibitor
0,202  0,132  Tyrosine 3 hydroxylase inhibitor
0,103  0,033  Antibiotic
0,097  0,029  Lipase inhibitor
0,116  0,048  Sulfotransferase substrate
0,095  0,028  Narcotic antagonist
0,124  0,059  Antiviral (Influenza B)
0,088  0,024  Aromatase inhibitor
0,077  0,015  Postcoital contraceptive
0,169  0,108  Anticonvulsant
0,078  0,018  Sphingosine kinase inhibitor
0,107  0,047  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,091  0,033  Peroxisome proliferator-activated receptor gamma agonist
0,103  0,046  Antifungal (Candida)
0,074  0,019  Sphingosine kinase 2 inhibitor
0,077  0,022  Hypercalcemia treatment
0,069  0,015  Vanilloid 2 antagonist
0,134  0,080  Lipid peroxidase inhibitor
0,101  0,047  Bile acid receptor antagonist
0,100  0,047  Androgen antagonist
0,058  0,006  Protein 30S ribosomal subunit inhibitor
0,138  0,088  Phospholipase A2 inhibitor
0,225  0,176  Histamine release inhibitor
0,056  0,009  Kainate receptor agonist
0,064  0,018  Oleamide hydrolase inhibitor
0,134  0,091  Acetylcholine M1 receptor antagonist
0,115  0,072  Topoisomerase II inhibitor
0,063  0,023  Nicotinic alpha3beta2 receptor antagonist
0,049  0,008  ATP citrate lysase inhibitor
0,048  0,009  Tubulin agonist
0,119  0,080  Antihyperlipoproteinemic
0,070  0,032  Antimycoplasmal
0,172  0,134  Acute neurologic disorders treatment
0,067  0,030  Prolactin release inhibitor
0,188  0,151  Flavin-containing monooxygenase substrate
0,057  0,020  Cholesterol esterase inhibitor
0,137  0,101  CF transmembrane conductance regulator agonist
0,049  0,014  Retinoid X receptor antagonist
0,092  0,058  Thioredoxin inhibitor
0,055  0,021  Microtubule stabilization
0,089  0,056  Antineoplastic alkaloid
0,062  0,029  Protein 50S ribosomal subunit inhibitor
0,101  0,069  Topoisomerase I inhibitor
0,044  0,013  Melatonin 2 agonist
0,070  0,040  Leukotriene antagonist
0,119  0,088  Antihemorrhagic
0,088  0,058  Interleukin 5 antagonist
0,068  0,040  HIV-1 integrase (3'-Processing) inhibitor
0,044  0,016  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,113  0,086  Acetylcholinesterase inhibitor
0,078  0,051  Keratolytic
0,184  0,158  Transcription factor STAT3 inhibitor
0,046  0,020  Estrogen receptor beta agonist
0,127  0,102  NOS3 expression enhancer
0,067  0,041  CDC25B inhibitor
0,046  0,021  Sphingosine kinase 1 inhibitor
0,057  0,032  Leukotriene B4 antagonist
0,146  0,121  Non-steroidal antiinflammatory agent
0,031  0,008  Prostaglandin F2 alpha agonist
0,055  0,033  Estrogen agonist
0,025  0,003  Antibiotic Tetracycline-like
0,099  0,078  Cystathionine beta-synthase inhibitor
0,104  0,084  Alkylator
0,113  0,096  Cocaine dependence treatment
0,054  0,038  Cannabinoid CB2 receptor agonist
0,133  0,117  Carcinogenic, group 1
0,036  0,020  Retinoid X alpha receptor antagonist
0,035  0,020  Calcium-independent phospholipase A2 inhibitor
0,037  0,022  Estrogen receptor alpha agonist
0,028  0,016  Nicotinic acid receptor 2 antagonist
0,025  0,013  Retinoic acid receptor agonist
0,137  0,126  Cardiodepressant
0,184  0,173  Gastrin inhibitor
0,108  0,098  Antifungal (Pneumocystis)
0,021  0,011  Progesterone receptor B antagonist
0,023  0,013  Vitamin D receptor antagonist
0,088  0,080  Glutathione S-transferase substrate
0,046  0,040  Antiviral (Herpesvirus 3, Human)
0,151  0,144  Antineoplastic (lymphoma)
0,183  0,177  Metabolic disease treatment
0,026  0,021  Retinoid X gamma receptor antagonist
0,021  0,016  Leukotriene B4 receptor 2 antagonist
0,019  0,015  Retinoic acid beta receptor agonist
0,022  0,017  Retinoic acid gamma receptor agonist
0,031  0,027  Melatonin 1 agonist
0,077  0,074  GST P1-1 substrate
0,042  0,040  Parathyroid hormone antagonist
0,024  0,023  Leukotriene B4 receptor 1 antagonist
0,030  0,030  Retinoid X alpha receptor agonist
0,062  0,061  Glutamate (mGluR6) antagonist
0,014  0,013  Prostacyclin agonist

